ANXA5 and neoplasm: Following TC-1 tumor challenge, cisplatin treatment, and/or AnxA5 administration, we harvested the tumor tissues from tumor-bearing mice and assessed the presence of various immune cell populations and cytokines within the TME (Fig. 2a).